FDA · Medical device recall
Sperm separation media are used to separate motile sperm from other constituents of semen
- Date
- Feb. 14, 2024
- Risk class
- Class II (FDA's definition, 21 CFR 7.3(m): a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote)
- Status
- Ongoing
- Filed by
- Fujifilm Irvine Scientific, Inc.
- Product
- Sperm separation media are used to separate motile sperm from other constituents of semen.
- Reason
- The lower layer component of a sperm separation Kit does not match the certificate of analysis. The kit should contain lower layer (Lot: 0000020686, Shelf Life: 31 December 2024) but incorrectly may contain lower layer (Lot number 9925811106, Shelf Life: 30 November 2023).
- Distribution pattern
- US: OK, CA, DC, NC, NV, TX, MI, IN, NY, UT, WI, MN, PA, WV, NJ, IL, LA, WA, OR, FL, IA. OUS: GB, NL, AR, MY
- Quantity
- 246
- Codes and lots
- UDI-DI: 00857515006009, Lot 0000020693
- Recall started
- Nov. 2, 2023
- Device type
- Media, Reproductive
- Root cause (FDA)
- Mixed-up of materials/components
- What the company told customers
- On 11/2/23, recall notices were distributed to customers who were asked to do the following: 1) Review inventory and if the lower layer is incorrect, per the COA, stopusingtheFISIProduct,return/destroyit,andrequestareplacementorcredit. 2)ThisnoticeneedstobepassedontoallthosewhoneedtobeawarewithinyourorganizationortoanyorganizationwherethepotentiallyaffectedProducthasbeentransferred. 2) Complete and return the return response form via email to fisira@fujifilm.com For customers requiring furtherinformationorsupport, contact firm customer service at 1-800-577-6097 orfisitmrequest@fujifilm.com
- Recall number
- Z-0998-2024
What should I do? How serious is a recall? Classes and warnings explained
Source: FDA · Medical device enforcement report, recall number Z-0998-2024. The agency record governs; check it and the company before acting.